$MOJO
EQUATOR Beverage Company

2024 Q1 Form 10-K Financial Statement

#000147793224001422 Filed on March 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2023
Revenue $640.7K $508.2K $2.288M
YoY Change 24.25% 44.48% 25.63%
Cost Of Revenue $370.1K $288.0K $1.276M
YoY Change 18.06% 28.37% 7.21%
Gross Profit $270.6K $220.2K $1.012M
YoY Change 33.84% 72.83% 60.37%
Gross Profit Margin 42.24% 43.34% 44.22%
Selling, General & Admin $368.7K $363.3K $1.175M
YoY Change 89.18% 89.95% 36.82%
% of Gross Profit 136.28% 164.94% 116.17%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $368.7K $363.3K $1.175M
YoY Change 89.18% 89.95% 36.82%
Operating Profit -$98.16K -$143.0K -$163.6K
YoY Change -1451.32% 124.13% -28.3%
Interest Expense $4.219K $13.10K
YoY Change 51.76% 23.15%
% of Operating Profit
Other Income/Expense, Net -$4.220K -$3.110K -$13.10K
YoY Change 51.8% -10.63% 23.16%
Pretax Income -$102.4K -$146.1K -$176.7K
YoY Change -2382.7% 117.18% -26.01%
Income Tax -$10.68K $3.240K -$54.02K
% Of Pretax Income
Net Earnings -$103.0K -$149.4K -$180.0K
YoY Change -2396.99% 122.0% -24.65%
Net Earnings / Revenue -16.08% -29.39% -7.86%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.01 -$0.01
COMMON SHARES
Basic Shares Outstanding 17.13M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q1 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $55.10K $87.34K $87.34K
YoY Change 35.55% 713.22% 713.22%
Cash & Equivalents $55.10K $87.34K $87.34K
Short-Term Investments
Other Short-Term Assets $23.20K $88.31K $88.31K
YoY Change -51.07% 29.39% 29.39%
Inventory $491.0K $270.8K $270.8K
Prepaid Expenses $23.20K $35.65K
Receivables $271.4K $135.1K $135.1K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $840.7K $581.5K $581.5K
YoY Change 76.03% 31.82% 31.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $840.7K $581.5K $581.5K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $840.7K $581.5K $581.5K
YoY Change 76.03% 31.82% 31.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $190.2K $80.62K $80.62K
YoY Change 143.09% 14.76% 14.76%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $360.0K $230.0K $230.0K
YoY Change 53.19% 2.22% 2.22%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $550.2K $310.6K $310.6K
YoY Change 75.65% 5.21% 5.21%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $550.2K $310.6K $310.6K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $550.2K $310.6K $310.6K
YoY Change 75.65% 5.21% 5.21%
SHAREHOLDERS EQUITY
Retained Earnings -$23.91M -$23.81M
YoY Change 1.22% 0.76%
Common Stock $24.20M $16.93K
YoY Change 1.74% 4.33%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $290.5K $270.9K $270.9K
YoY Change
Total Liabilities & Shareholders Equity $840.7K $581.5K $581.5K
YoY Change 76.03% 31.82% 31.82%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$103.0K -$149.4K -$180.0K
YoY Change -2396.99% 122.0% -24.65%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$162.2K $110.8K $123.4K
YoY Change -914.95% 116.8% -232.7%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $130.0K -23.81K -$46.81K
YoY Change 1200.0% -52.38% -181.76%
NET CHANGE
Cash From Operating Activities -$162.2K 110.8K $123.4K
Cash From Investing Activities
Cash From Financing Activities $130.0K -23.81K -$46.81K
Net Change In Cash -$32.24K 87.02K $76.60K
YoY Change -207.8% 7669.64% -314.31%
FREE CASH FLOW
Cash From Operating Activities -$162.2K $110.8K $123.4K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-238836 usd
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001414953
CY2023 dei Amendment Flag
AmendmentFlag
false
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022 mojo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
15841585 shares
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87339 usd
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16230615 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16933346 shares
CY2023 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-180060 usd
CY2023 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-37813 usd
CY2023 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-16205 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023 dei Document Type
DocumentType
10-K
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Document Period End Date
DocumentPeriodEndDate
2023-12-31
CY2023 dei Document Transition Report
DocumentTransitionReport
false
CY2023 dei Entity File Number
EntityFileNumber
000-55269
CY2023 dei Entity Registrant Name
EntityRegistrantName
EQUATOR Beverage Company
CY2023 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-0884348
CY2023 dei Entity Address Address Line1
EntityAddressAddressLine1
185 Hudson Street
CY2023 dei Entity Address Address Line2
EntityAddressAddressLine2
Floor 25
CY2023 dei Entity Address City Or Town
EntityAddressCityOrTown
Jersey City
CY2023 dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
CY2023 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07302
CY2023 dei City Area Code
CityAreaCode
929
CY2023 dei Local Phone Number
LocalPhoneNumber
264 7944
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $0.001 par value per share
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Public Float
EntityPublicFloat
1443842 usd
CY2024Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
17134346 shares
CY2023 dei Auditor Name
AuditorName
Victor Mokuolu, CPA PLLC
CY2023 dei Auditor Firm
AuditorFirmId
6771
CY2023 dei Auditor Location
AuditorLocation
Houston, Texas
CY2023 dei Auditor Firm
AuditorFirmId
6771
CY2023 us-gaap Revenues
Revenues
2288272 usd
CY2022 us-gaap Revenues
Revenues
1821492 usd
CY2023 us-gaap Cost Of Revenue
CostOfRevenue
1276411 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
1190536 usd
CY2023 us-gaap Gross Profit
GrossProfit
1011861 usd
CY2022 us-gaap Gross Profit
GrossProfit
630956 usd
CY2023 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1175478 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
859155 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
1175478 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
859155 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-163617 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-228199 usd
CY2023 us-gaap Interest Expense
InterestExpense
13099 usd
CY2022 us-gaap Interest Expense
InterestExpense
10637 usd
CY2023 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-176716 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-238836 usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-54018 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
50777 usd
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-179957 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-238836 usd
CY2023 mojo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.01
CY2022 mojo Earning Per Share Basic And Diluted
EarningPerShareBasicAndDiluted
-0.02
CY2023 mojo Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
16660452 shares
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10738 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
135061 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
93852 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
270788 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
268289 usd
CY2023Q4 us-gaap Retainage Deposit
RetainageDeposit
52655 usd
CY2022Q4 us-gaap Retainage Deposit
RetainageDeposit
44772 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
35650 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
23468 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
581493 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
441119 usd
CY2023Q4 us-gaap Assets
Assets
581493 usd
CY2022Q4 us-gaap Assets
Assets
441119 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
80621 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
70252 usd
CY2023Q4 mojo Due To Related Party Current
DueToRelatedPartyCurrent
230000 usd
CY2022Q4 mojo Due To Related Party Current
DueToRelatedPartyCurrent
225000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
310621 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
295252 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16933346 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16230615 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
16934 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
16231 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
24063176 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23758917 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23809238 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23629281 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
270872 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
145867 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
581493 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
441119 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
370553 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
181889 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25449 usd
CY2022 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-193188 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-238836 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
145867 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
356776 usd
CY2023 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-51814 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-179957 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
270872 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-179957 usd
CY2023 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
356776 usd
CY2022 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
181889 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-41209 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14783 usd
CY2023 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-2499 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-33723 usd
CY2023 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-7883 usd
CY2022 us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
-16772 usd
CY2023 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-12182 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-11653 usd
CY2023 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10369 usd
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11308 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
123415 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-93004 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
230000 usd
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
510000 usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
225000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
285000 usd
CY2023 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
25449 usd
CY2023 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
51814 usd
CY2022 us-gaap Payments For Repurchase Of Equity
PaymentsForRepurchaseOfEquity
193188 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-46814 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
57261 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
76601 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-35743 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10738 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
46481 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87339 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10738 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
13100 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
10641 usd
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:left;">The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). Management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
3796573 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
3739625 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
56948 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
3616513 usd
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
3796573 usd
CY2022Q4 mojo Deferred Tax Assets Gross Federal Beginning
DeferredTaxAssetsGrossFederalBeginning
797280 usd
CY2021Q4 mojo Deferred Tax Assets Gross Federal Beginning
DeferredTaxAssetsGrossFederalBeginning
785321 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
11959 usd
CY2023Q4 mojo Deferred Tax Assets Gross Federal
DeferredTaxAssetsGrossFederal
759468 usd
CY2022Q4 mojo Deferred Tax Assets Gross Federal
DeferredTaxAssetsGrossFederal
797280 usd
CY2022Q4 mojo Deferred Tax Asset Gross State And Local
DeferredTaxAssetGrossStateAndLocal
341107 usd
CY2021Q4 mojo Deferred Tax Asset Gross State And Local
DeferredTaxAssetGrossStateAndLocal
336254 usd
CY2022 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
4854 usd
CY2023Q4 mojo Deferreds Tax Assets Gross State And Local
DeferredsTaxAssetsGrossStateAndLocal
324902 usd
CY2022Q4 mojo Deferreds Tax Assets Gross State And Local
DeferredsTaxAssetsGrossStateAndLocal
341107 usd
CY2023Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1084370 usd
CY2022Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
1138388 usd
CY2023 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
54018 usd
CY2022 us-gaap Other Tax Expense Benefit
OtherTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-2 reverse split
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
40000000 shares
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
effect a 1-for-2 reverse split of the Company’s Common Stock.
CY2023Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
276000 shares
CY2023Q1 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
16192 usd
CY2022Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
663000 shares
CY2022Q1 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
111968 usd
CY2023Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
276000 shares
CY2023Q2 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
30360 usd
CY2022Q2 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
138000 shares
CY2022Q2 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
24104 usd
CY2023Q3 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
112016 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
238500 shares
CY2022Q3 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
23850 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
313500 shares
CY2023Q4 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
198209 usd
CY2022Q4 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
313500 shares
CY2022Q4 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
21967 usd
CY2023 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
1104000 shares
CY2023 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
356777 usd
CY2022 us-gaap Restricted Stock Award Forfeitures
RestrictedStockAwardForfeitures
181889 usd
CY2023 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
401269 shares
CY2023 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
51814 usd
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.16
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.16

Files In Submission

Name View Source Status
0001477932-24-001422-index-headers.html Edgar Link pending
0001477932-24-001422-index.html Edgar Link pending
0001477932-24-001422.txt Edgar Link pending
0001477932-24-001422-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mojo-20231231.xsd Edgar Link pending
mojo_10k.htm Edgar Link pending
mojo_10kimg1.jpg Edgar Link pending
mojo_ex311.htm Edgar Link pending
mojo_ex321.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
mojo-20231231_cal.xml Edgar Link unprocessable
mojo-20231231_def.xml Edgar Link unprocessable
mojo-20231231_lab.xml Edgar Link unprocessable
mojo-20231231_pre.xml Edgar Link unprocessable
mojo_10k_htm.xml Edgar Link completed
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable